Targeting MLCK1 Uncouples Immune Checkpoint Inhibitor-Induced Colitis from Antitumour Immunity

Researchers investigated long myosin light chain kinase 1 (MLCK1), a known regulator of tight junction and gut permeability, to elucidate the mechanisms underlying immune checkpoint inhibitor-mediated colitis and identified approaches to reduce this toxicity.